BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9835417)

  • 1. Considerations for in vitro monoclonal antibody production.
    Peterson NC
    Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417
    [No Abstract]   [Full Text] [Related]  

  • 2. Hollow fibre bioreactors: an alternative to murine ascites for small scale (<1 gram) monoclonal antibody production.
    Lipman NS; Jackson LR
    Res Immunol; 1998; 149(6):571-6. PubMed ID: 9835420
    [No Abstract]   [Full Text] [Related]  

  • 3. Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies.
    Marx U
    Res Immunol; 1998; 149(6):557-9. PubMed ID: 9835418
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Introduction.
    de Geus B; Hendriksen CF
    Res Immunol; 1998; 149(6):533-4. PubMed ID: 9835413
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of small to moderate scale in vitro monoclonal antibody production via the use of the i-MAb gas-permeable bag system.
    Lipski LA; Witzleb MP; Reddington GM; Reddington JJ
    Res Immunol; 1998; 149(6):547-52. PubMed ID: 9835416
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody production: problems and solutions.
    Falkenberg FW
    Res Immunol; 1998; 149(6):542-7. PubMed ID: 9835415
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Discussion.
    Hendriksen CF; de Leeuw WA
    Res Immunol; 1998; 149(6):611-20. PubMed ID: 9835427
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of monoclonal antibody supernatant and ascites fluid.
    Yokoyama WM
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.10. PubMed ID: 18265068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods.
    Falkenberg FW
    Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
    Trebak M; Chong JM; Herlyn D; Speicher DW
    J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro production of monoclonal antibodies. Bioreactors vs immune ascites.
    Marx U; Merz W
    Methods Mol Biol; 1995; 45():169-76. PubMed ID: 7550678
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of monoclonal antibody supernatant and ascites fluid.
    Yokoyama WM
    Curr Protoc Mol Biol; 2008 Jul; Chapter 11():Unit 11.10. PubMed ID: 18633992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies by the ascites method in laboratory animals.
    Hendriksen CF; de Leeuw W
    Res Immunol; 1998; 149(6):535-42. PubMed ID: 9835414
    [No Abstract]   [Full Text] [Related]  

  • 14. Harvesting Tissue from Immunized Mice, Rats, and Hamsters.
    Greenfield EA
    Cold Spring Harb Protoc; 2017 Nov; 2017(11):pdb.prot100362. PubMed ID: 29093208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
    Bruce MP; Boyd V; Duch C; White JR
    J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybridoma cells immobilized on nonwoven polyester fabric discs: proliferation and monoclonal antibody production in stationary culture.
    Aslankaraoğlu E; Gümüşderelioğlu M; Gürhan SI
    J Biomater Appl; 2003 Oct; 18(2):137-48. PubMed ID: 14621339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of human monoclonal antibody in mouse ascites.
    Truitt KE; Larrick JW; Raubitschek AA; Buck DW; Jacobson SW
    Hybridoma; 1984; 3(2):195-9. PubMed ID: 6480025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technics of monoclonal antibody production with hybridomas and their medical application].
    Yamamoto K; Nakauchi H; Okumura K
    Nihon Rinsho; 1981; 39(12):3788-95. PubMed ID: 7040735
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods of measuring antibodies in sera/plasma, ascites, and tissue-culture media.
    Rudbach JA; Cantrell JL; Ulrich JT
    Methods Mol Biol; 1995; 45():79-82. PubMed ID: 7550695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.